Stabilization of HIF-1α is critical to improve wound healing in diabetic mice

Abstract

Relative hypoxia is essential in wound healing since it normally plays a pivotal role in regulation of all the critical processes involved in tissue repair. Hypoxia-inducible factor (HIF) 1 alpha is the critical transcription factor that regulates adaptive responses to hypoxia. HIF-1 alpha stability and function is regulated by oxygen-dependent soluble hydroxylases targeting critical proline and asparaginyl residues. Here we show that hyperglycemia complexly affects both HIF-1 alpha stability and activation, resulting in suppression of expression of HIF-1 target genes essential for wound healing both in vitro and in vivo. However, by blocking HIF-1 alpha hydroxylation through chemical inhibition, it is possible to reverse this negative effect of hyperglycemia and to improve thewoundhealing process (i.e., granulation, vascularization, epidermal regeneration, and recruitment of endothelial precursors). Local adenovirus-mediated transfer of two stable HIF constructs demonstrated that stabilization of HIF-1 alpha is necessary and sufficient for promoting wound healing in a diabetic environment. Our findings outline the necessity to develop specific hydroxylase inhibitors as therapeutic agents for chronic diabetes wounds. In conclusion, we demonstrate that impaired regulation of HIF-1 alpha is essential for the development of diabetic wounds, and we provide evidence that stabilization of HIF-1 alpha is critical to reverse the pathological process.